Synapse - Seth Cohen

Results (21)

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Journal Article

Lumish, M.; Chui, M. H.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Cohen, S.; Friedman, C.; Grisham, R.; Konner, J.; Kyi, C.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma

Meeting Abstract

Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma

Meeting Abstract

Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Nacev, B. A.; Rosenbaum, E.; Thornton, K. A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)

Meeting Abstract

Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)

Meeting Abstract

Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Immunotherapy for recurrent or metastatic vulvar carcinoma: A case report and review of current guidelines

Journal Article

Praiss, A.; Navitski, A.; Cohen, S.; Tessier-Cloutier, B.; Broach, V.; O'Cearbhaill, R. E.
Gynecologic Oncology Reports (2022)

Fulltext@MSK | Save

COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic

Journal Article

Lara, O. D.; Smith, M.; Wang, Y.; O'Cearbhaill, R. E.; Blank, S. V.; Kolev, V.; Carr, C.; Knisely, A.; McEachron, J.; Gabor, L.; more...
Gynecologic Oncology (2022)

Fulltext@MSK | Save

TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition

Journal Article

Chiang, S.; Vasudevaraja, V.; Serrano, J.; Stewart, C. J. R.; Oliva, E.; Momeni-Boroujeni, A.; Jungbluth, A. A.; Da Cruz Paula, A.; da Silva, E. M.; Weigelt, B.; more...
Modern Pathology (2022)

Fulltext@MSK | Save

Basket study of the oral progesterone antagonist onapristone ER in women with progesterone receptor positive (PR plus ) recurrent granulosa cell tumor (GCT), low-grade serous ovarian cancer (LGSOC), or endometrioid endometrial cancer (EEC)